Trade Walgreen Boots Alliance - WBA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024818% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002596% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.33 |
| Open | 9.35 |
| 1-Year Change | -55.62% |
| Day's Range | 9.22 - 9.37 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 29, 2024 | 9.33 | 0.01 | 0.11% | 9.32 | 9.64 | 9.23 |
| Oct 28, 2024 | 9.42 | 0.09 | 0.96% | 9.33 | 9.52 | 9.26 |
| Oct 25, 2024 | 9.24 | -0.09 | -0.96% | 9.33 | 9.55 | 9.23 |
| Oct 24, 2024 | 9.30 | -0.05 | -0.53% | 9.35 | 9.56 | 9.25 |
| Oct 23, 2024 | 9.33 | -0.33 | -3.42% | 9.66 | 9.70 | 9.24 |
| Oct 22, 2024 | 9.71 | -0.66 | -6.36% | 10.37 | 10.51 | 9.60 |
| Oct 21, 2024 | 10.42 | -0.31 | -2.89% | 10.73 | 10.77 | 10.41 |
| Oct 18, 2024 | 10.76 | 0.12 | 1.13% | 10.64 | 10.86 | 10.30 |
| Oct 17, 2024 | 10.65 | -0.33 | -3.01% | 10.98 | 11.02 | 10.32 |
| Oct 16, 2024 | 11.06 | 0.62 | 5.94% | 10.44 | 11.08 | 10.21 |
| Oct 15, 2024 | 10.42 | 0.80 | 8.32% | 9.62 | 10.60 | 9.48 |
| Oct 14, 2024 | 8.97 | -0.27 | -2.92% | 9.24 | 9.42 | 8.89 |
| Oct 11, 2024 | 9.18 | 0.30 | 3.38% | 8.88 | 9.25 | 8.79 |
| Oct 10, 2024 | 9.00 | 0.15 | 1.69% | 8.85 | 9.01 | 8.79 |
| Oct 9, 2024 | 8.89 | -0.10 | -1.11% | 8.99 | 9.14 | 8.85 |
| Oct 8, 2024 | 9.06 | 0.28 | 3.19% | 8.78 | 9.06 | 8.73 |
| Oct 7, 2024 | 8.85 | 0.13 | 1.49% | 8.72 | 8.87 | 8.65 |
| Oct 4, 2024 | 8.70 | -0.12 | -1.36% | 8.82 | 8.90 | 8.69 |
| Oct 3, 2024 | 8.65 | 0.06 | 0.70% | 8.59 | 8.65 | 8.50 |
| Oct 2, 2024 | 8.67 | -0.05 | -0.57% | 8.72 | 9.01 | 8.67 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Walgreen Company profile
What is Walgreen Boots Alliance?
Walgreen Boots Alliance is one of the largest pharmacy chains in the world. It is is split into three business segments: Retail Pharmacy Wholesale, Retail Pharmacy USA and Retail Pharmacy International. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare. Among its health and beauty product brands are such household names as No7, Soap & Glory, Liz Earle and Botanics.
WBA also has one of the largest global pharmaceutical wholesale and distribution networks. The company is one of the world’s biggest purchasers of prescription drugs and many other health and wellbeing products. Walgreen Boots Alliance says its aim is to “help people across the world lead healthier and happier lives”.
Who are the key people at Walgreen Boots Alliance?
Stefano Pessina is Executive Vice Chairman and Chief Executive Officer of Walgreens Boots Alliance. The Italian-born billionaire’s career in the healthcare industry spans four decades. As Executive Deputy Chairman of Alliance UniChem, he led the company's landmark merger with Boots Group PLC in 2006. His voice carries a lot of weight in the sector.
WBA has two Co-Chief Operating Officers: Alex Gourlay and Ornella Barra. James A. Skinner serves as Executive Chairman.
What is the modern history of Walgreen Boots Alliance?
Walgreen Boots Alliance was established on December 31, 2014 after Walgreens, the US pharmacy store giant, purchased the 55% of Alliance Boots that it didn’t already own. Alliance Boots was a UK and Switzerland-based health and beauty group formed in 2006 through the merger of high street chain Boots and European pharmacy group Alliance UniChem.
What are the latest developments at Walgreen Boots Alliance?
It’s been a time of consolidation in the US healthcare industry, partly prompted by Amazon’s announcement that it is entering the sector to try to lower costs for patients. Some observers think Amazon could use its distribution expertise to undercut existing healthcare firms.
Walgreen Boots Alliance has been very active in pursuing potential deals. In September 2017, it agreed to buy 1,932 Rite Aid stores and three distribution centres for almost $4.4 billion in cash. WBA had previously sought to buy all of Rite Aid, but antitrust scrutiny scuppered the proposed deal.
In February 2018 it was reported that deal talks between Walgreens Boots Alliance and AmerisourceBergen about an acquisition of the wholesale drug distributor had ended without agreement. Walgreens already has a 26 per cent stake in Amerisource.
Since Walgreen Boots Alliance was founded at the end of 2014, the WBA share price has gone from $76 to a peak of $96 in July 2015 and back down to just $64 in October 2017. On 1 March 2018 the share price stood at $70.20, giving the company a market capitalisation of around $69.5 billion.
Our WBA chart tracks the ups and downs of the company’s share price over recent weeks and months.
Where does Walgreen Boots Alliance operate?
Walgreens Boots Alliance and the companies in which it has equity method investments have a presence in more than 25 countries around the world, with a total of over 13,000 stores. WBA also has one of the biggest global pharmaceutical wholesale and distribution networks, with over 390 distribution centres delivering to some 230,000 hospitals, health centres, pharmacies and doctors each year in over 20 countries. WBA is headquartered in Deerfield, Illinois.
Where is Walgreen Boots Alliance traded?
Walgreen is listed on the NASDAQ stock exchange. Check out Capital.com for the latest WBA chart.
| Industry: | Drug Retailers (NEC) |
108 Wilmot Rd
DEERFIELD
ILLINOIS 60015
US
News
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024
Gold markets to trade
Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.
08:00, 21 October 2024
US earnings seasons off to a solid start as focus shifts to tech giants
The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.
14:31, 17 October 2024
ECB Preview: cooling growth and inflation call for another rate cut
Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.
12:41, 16 October 2024
Australian labour force data forecast to reveal stable jobs market
Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.
07:41, 15 October 2024
Applying fundamental and technical strategies to Gold Trading
Last week, we visualised the key potential drivers of gold in a chart focused on recent performance. Understanding the factors that can move gold prices is essential, but translating that knowledge into effective trading strategies is where the real potential can lie.
08:00, 14 October 2024
S&P 500 expected to deliver modest earnings growth in Q3
Earnings growth across the S&P 500 is expected to be modest in Q3, with a projected 4.2% increase in EPS, down from 7.8% in the previous quarter. Information technology, health care, and communication services are poised to drive growth, particularly IT with a forecasted 15% year-over-year EPS increase.
12:40, 11 October 2024People also watch
Still looking for a broker you can trust?
Join the 650,000+ traders worldwide that chose to trade with Capital.com